NLS Pharmaceutics and Kadimastem Advance Diabetes Treatment with FDA Submission
NLS Pharmaceutics ( (NLSP) ) has shared an update.
NLS Pharmaceutics, Kadimastem submit request for FDA pre-IND meeting
NLS Pharmaceutics (NLSP) and Kadimastem, announced in collaboration with iTolerance, that a request for a Pre-Investigational New Drug meeting ...
Goodbye diabetes: a promising cure advances giving hope to 800 million people
An innovative treatment based on harmine and alpha cells could transform diabetes treatment and reduce insulin dependence ...
Universiteit Utrecht6d
Nineteen Utrecht researchers receive NWO award for groundbreaking fundamental research
A total of nearly 64 million euros has been awarded in the NWO Open Competition ENW-XL. The program funds consortia for curiosity-driven, untied fundamental research in the research areas of the NWO's ...